Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer. - de Mooij CM; Simons JM; van Amstel FJG; Mitea C; van Diest PJ; Nelemans PJ; Mottaghy FM; van der Pol CC; Luiten EJT; Koppert LB; Smidt ML; van Nijnatten TJA (Breast (Edinburgh, Scotland), 2026)